
BioGrid Australia Ltd is a not-for-profit company limited by guarantee with charity status owned by the Australian medical research industry. Company members are those parties that have signed the BioGrid Australia Collaboration Agreement and include a number of Australian health service organisations, medical research institutes and universities.
Data governance and patient privacy are at the core of BioGrid’s federated data sharing platform that securely links patient level clinical, bio-specimen, genetic variance, imaging and administrative datasets from multiple sources for the purpose of ethically approved medical research.
An independent Board of Directors governs BioGrid. BioGrid’s Member Management Committee provides direction to the BioGrid management team in accordance with the provisions of the Collaboration Agreement.
BioGrid empowers data-driven decisions by connecting health information enabling researchers to ethically capture, link, analyse privacy-protected data more efficiently and cost-effectively than ever before. BioGrid provides vital governance and technical support to researchers across Australia by providing them with authorised access to coded (i.e. with personally identifying information removed) real time clinical, genomic, imaging and administrative data from health institutions and jurisdictions across Australia.
Only authorised researchers with approval from data custodians as well as approval from an accredited Human Research Ethics Committee for their research study are permitted to access coded (i.e. with personally identifying information removed) data from BioGrid; this is managed through BioGrid’s Access Request System. Personal identifiers are stored separately from clinical information within BioGrid and are inaccessible to researchers; researchers can only access coded data through BioGrid.
BioGrid is highly committed to protecting the security of data it manages and the privacy and confidentiality of participants to whom the data pertains. Significant efforts have been made to minimise the risk of a breach of data security. State of the art techniques are used to encrypt and transmit data when accessed for research.
BioGrid has implemented systems and processes to ensure the privacy and confidentiality of participant data within its research platform. This covers regular monitoring and management of all systems such as monitoring access including unsuccessful attempts to access the BioGrid network and applying relevant security patches across the BioGrid ICT network.
Information and data within the BioGrid secure ICT network is only made available for authorised researchers to access if the following is in place:
BioGrid uses a proven Information Security Risk Management framework that fully complies with, and in some areas, exceeds the requirements specified in the international standard, ISO 27005.
BioGrid has regular independent security audits conducted and has documented and manages the residual risks identified. External audits assess BioGrid for its compliance to policy and examine practices in remote access, network, side channels and virtual private networks. In addition, the external audit assesses and reports on the practices BioGrid Australia has in place for monitoring and reporting the state of ICT security.
BioGrid has implemented several security systems and processes to protect data against misuse, loss and unauthorised access. Security measures include:
Data security is of the utmost importance to BioGrid. Should you have any further queries regarding the security of data within BioGrid or how BioGrid manages authorised access to data, please contact us.
We know that trust in the security of our services and systems is critical, and the information in the pages in this section provide more information about how we achieve this.

BioGrid's privacy charter ensures ethical data use, confidentiality, and secure transactions, emphasising joint intellectual property ownership and consent for publications.

BioGrid Australia uses coded patient data, separated for privacy, in collaborative research on chronic diseases, ensuring confidentiality and offering opt-out options.